Atorvastatin in Factorial with Omega-3 Fatty Acids Risk Reduction in Diabetes

Conference abstracts (1 of 3)

Years :

Search conference abstracts :


Diabetes UK Annual Professional Conference, Glasgow
AFORRD: a multi-centre trial evaluating potential cardiovascular risk reduction in patients with type 2 diabetes randomised in a factorial design to atorvastatin and/or omega-3 polyunsaturated fatty acids
Farmer AJ,Neil HAW, Holman RR
Diabetic Medicine 2005;22:S2:63